TY - JOUR
T1 - Epidermal growth factor receptor (EGFR) mutation testing, from bench to practice
T2 - A single institute experience
AU - Shikhrakab, Hassan
AU - Elamin, Yasir Y.
AU - O'Brien, Cathal
AU - Gately, Kathy
AU - Finn, Stephen
AU - O'Byrne, K.
AU - Osman, Nemer
PY - 2014
Y1 - 2014
N2 - Epidermal growth factor receptor (EGFR) gene mutations determine the treatment and prognosis in lung adenocarcinoma. Exon 19 and exon 21 (L858R) deletions represent the most common recognised mutations detected. To date, no figures regarding the prevalence of EGFR mutations in the Irish population have been published. The prevalence of EGFR mutations was retrospectively analysed for all patient samples tested since the introduction of EGFR testing routinely (Mar to Dec 2012) in a single Irish institute. The presence of 41 known treatment linked EGFR mutations in exons 18, 19, 20 and 21 of the EGFR gene was tested in 209 Irish patients. Resection, core biopsy or FNA samples were analysed using a commercially available CE-IVD marked multiplex real-time PCR assay. Samples were included from patients of curative and palliative treatment intent likely to harbour an EGFR mutation.
AB - Epidermal growth factor receptor (EGFR) gene mutations determine the treatment and prognosis in lung adenocarcinoma. Exon 19 and exon 21 (L858R) deletions represent the most common recognised mutations detected. To date, no figures regarding the prevalence of EGFR mutations in the Irish population have been published. The prevalence of EGFR mutations was retrospectively analysed for all patient samples tested since the introduction of EGFR testing routinely (Mar to Dec 2012) in a single Irish institute. The presence of 41 known treatment linked EGFR mutations in exons 18, 19, 20 and 21 of the EGFR gene was tested in 209 Irish patients. Resection, core biopsy or FNA samples were analysed using a commercially available CE-IVD marked multiplex real-time PCR assay. Samples were included from patients of curative and palliative treatment intent likely to harbour an EGFR mutation.
UR - http://www.scopus.com/inward/record.url?scp=84905675464&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905675464&partnerID=8YFLogxK
M3 - Article
C2 - 25226713
AN - SCOPUS:84905675464
SN - 0332-3102
VL - 107
JO - Irish medical journal
JF - Irish medical journal
IS - 7
ER -